ScoreWhy is Beijing Konruns Pharmaceutical Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 5.40%
- The company has been able to generate a Return on Capital Employed (avg) of 5.40% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of -0.37% and Operating profit at 2.05% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 5.07% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of -0.37% and Operating profit at 2.05% over the last 5 years
4
Flat results in Jun 26
- DEBTORS TURNOVER RATIO(HY) Lowest at 2.35 times
- INTEREST(Q) Highest at CNY 2.39 MM
5
With ROE of 5.15%, it has a expensive valuation with a 1.41 Price to Book Value
- Over the past year, while the stock has generated a return of -47.77%, its profits have risen by 35.8% ; the PEG ratio of the company is 0.8
- At the current price, the company has a high dividend yield of 0
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Beijing Konruns Pharmaceutical Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Beijing Konruns Pharmaceutical Co., Ltd.
-43.11%
0.34
47.82%
China Shanghai Composite
3.0%
0.22
14.72%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-0.37%
EBIT Growth (5y)
2.05%
EBIT to Interest (avg)
51.01
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
0.26
Tax Ratio
11.85%
Dividend Payout Ratio
33.33%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.78%
ROE (avg)
5.07%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
27
Industry P/E
Price to Book Value
1.41
EV to EBIT
22.45
EV to EBITDA
19.46
EV to Capital Employed
1.48
EV to Sales
4.45
PEG Ratio
0.76
Dividend Yield
NA
ROCE (Latest)
6.58%
ROE (Latest)
5.15%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
ROCE(HY)
Highest at 5.41%
RAW MATERIAL COST(Y)
Fallen by 1.39% (YoY
PRE-TAX PROFIT(Q)
Highest at CNY 60.44 MM
EPS(Q)
Highest at CNY 0.31
-11What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.35 times
INTEREST(Q)
Highest at CNY 2.39 MM
Here's what is working for Beijing Konruns Pharmaceutical Co., Ltd.
Pre-Tax Profit
Highest at CNY 60.44 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
EPS
Highest at CNY 0.31
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Raw Material Cost
Fallen by 1.39% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Beijing Konruns Pharmaceutical Co., Ltd.
Interest
Highest at CNY 2.39 MM
in the last five periods and Increased by 8.73% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Debtors Turnover Ratio
Lowest at 2.35 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Footer loading
